Form 4 for TCRT Alaunos Therapeutics, Inc.
Accepted 2022-12-01 00:00:00 ET · period of report 2022-11-29 · accession 0000899243-22-037275 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-12-01 | 2022-11-29 | TCRT | Postma Robert W | Dir | P - Purchase | $0.65 | +750.0K | 5.00M | +18% | +$487.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-29 | P | A | 750,000 | $0.65 | 5,000,000 | I By WaterMill Asset Management Corp. | — | — | (F1) The shares are directly held by WaterMill Asset Management Corp. The Reporting Person serves as the principal of WaterMill Asset Management Corp. (F2) The shares were purchased in a registered underwritten offering on November 29, 2022. |